Nomura Asset Management CO LTD Aurinia Pharmaceuticals Inc. Transaction History

Nomura Asset Management CO LTD

14 transactions

Quarter	Operation	Price Per share	shares change
Q1 2022 May 13, 2022	SELL	$10.05 - $22.48 $0 - $0	0 Closed
Q4 2021 Jan 10, 2025	BUY	$17.78 - $33.08 $0 - $0	0 New
Q4 2021 Feb 01, 2022	BUY	$17.78 - $33.08 $0 - $0	0 New
Q3 2021 Jan 10, 2025	BUY	$10.93 - $23.55 $0 - $0	0 New
Q3 2021 Nov 12, 2021	BUY	$10.93 - $23.55 $0 - $0	0 New
Q2 2021 Jan 10, 2025	BUY	$10.0 - $14.52 $0 - $0	0 New
Q2 2021 Aug 06, 2021	BUY	$10.0 - $14.52 $0 - $0	0 New
Q1 2021 Jan 10, 2025	BUY	$12.3 - $18.73 $0 - $0	0 New
Q1 2021 May 14, 2021	BUY	$12.3 - $18.73 $0 - $0	0 New
Q4 2020 Jan 10, 2025	BUY	$12.94 - $16.05 $0 - $0	0 New
Q4 2020 Feb 12, 2021	BUY	$12.94 - $16.05 $0 - $0	0 New
Q3 2020 Nov 12, 2020	BUY	$13.19 - $16.66 $0 - $0	0 New
Q2 2020 Aug 13, 2020	BUY	$14.12 - $18.33 $0 - $0	0 New
Q1 2020 May 14, 2020	BUY	$11.34 - $21.46 $0 - $0	0 New

210

58.2M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.1B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.